All Cosmos Bio-Tech Holding Management
Management criteria checks 1/4
All Cosmos Bio-Tech Holding's CEO is Tony Peng, appointed in Sep 2012, has a tenure of 12.25 years. directly owns 35.52% of the company’s shares, worth NT$1.03B. The average tenure of the management team and the board of directors is 8.7 years and 2.5 years respectively.
Key information
Tony Peng
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.3yrs |
| CEO ownership | 35.5% |
| Management average tenure | 8.7yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
There May Be Reason For Hope In All Cosmos Bio-Tech Holding's (TWSE:4148) Disappointing Earnings
Mar 22
Is All Cosmos Bio-Tech Holding (TPE:4148) Using Too Much Debt?
Apr 20Returns On Capital At All Cosmos Bio-Tech Holding (TPE:4148) Paint An Interesting Picture
Jan 10
All Cosmos Bio-Tech Holding Corporation's (TPE:4148) Price Is Out Of Tune With Earnings
Dec 22Are Poor Financial Prospects Dragging Down All Cosmos Bio-Tech Holding Corporation (TPE:4148 Stock?
Dec 01CEO
Tony Peng (49 yo)
12.3yrs
Tenure
Dato' Dr. Shih Hao Peng, also known as Tony, Ph.D. serves as Chief Executive Officer at ALL Cosmos Industries Sdn Bhd. He serves as the Chairman of the Board of All Cosmos Bio-Tech Holding Corporation and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 12.3yrs | no data | 35.52% NT$ 1.0b | |
| Chief Financial Officer | 8.7yrs | no data | no data | |
| AESB Chief Executive Officer | less than a year | no data | no data |
8.7yrs
Average Tenure
Experienced Management: 4148's management team is seasoned and experienced (8.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 14.8yrs | no data | 35.52% NT$ 1.0b | |
| Non Independent Director | 2.5yrs | no data | no data | |
| Representative Director | 10.5yrs | no data | 0.13% NT$ 3.7m | |
| Independent Director | 10.5yrs | no data | no data | |
| Independent Director | 5.5yrs | no data | no data | |
| Independent Director | 2.5yrs | no data | no data | |
| Independent Director | 2.5yrs | no data | no data | |
| Non Independent Director | 2.5yrs | no data | 0.017% NT$ 499.4k | |
| Non-Independent Director | 2.5yrs | no data | no data |
2.5yrs
Average Tenure
Experienced Board: 4148's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:03 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
All Cosmos Bio-Tech Holding Corporation is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xuanyi Yang | Capital Securities Corporation |
| Hsiu Chi Lin | Masterlink Securities Corp. |
| Yijun Chen | SinoPac Securities Investment Service |